Philippe Généreux, MD

Co-Director, Valve & Structural Heart Center
Morristown Medical Center
Morristown, New Jersey, United States

Philippe Généreux is an interventional cardiologist, Medical Director of the Structural Heart Program at the Gagnon Cardiovascular Institute at Morristown Medical Center, New Jersey.

Presentation(s):

• CARDIOTUBE INTERVIEW: Moderate AS and Asymptomatic AS the exit frontiers for TAVR

  Monday, February 27, 2023
  5:15 PM – 5:25 PM ET

  Disclosure information not submitted.

• Sensing Bleeding During Intervention

  Monday, February 27, 2023
  11:02 AM – 11:10 AM ET

  Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)

• Cardio-Renal Support with the Novel Puzzle Medical ModulHeart Pump

  Monday, February 27, 2023
  11:26 AM – 11:34 AM ET

  Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)

• Panel Discussion | Questions and Answers

  Monday, February 27, 2023
  11:42 AM – 12:00 PM ET

  Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)

• Power Break Symposium: Live Case from Tucson Medical Center | Tucson, AZ (Non-CME)

  Monday, February 27, 2023
  12:45 PM – 1:30 PM ET

  Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)

• Short Cut for Prevention of Coronary Obstruction Post Valve in Valve OUS Experience

  Monday, February 27, 2023
  3:21 PM – 3:29 PM ET

  Disclosure information not submitted.

• Should Patients with Asymptomatic AS Undergo TAVR

  Monday, February 27, 2023
  4:32 PM – 4:40 PM ET

  Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)

• Panel Discussion: Practical and Hot Topics

  Monday, February 27, 2023
  5:20 PM – 5:45 PM ET

  Disclosure(s): Puzzle Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Shareholder (Ongoing)